{"id":3664,"date":"2025-04-01T16:15:55","date_gmt":"2025-04-01T20:15:55","guid":{"rendered":"https:\/\/www.accessforkidscancer.ca\/?p=3664"},"modified":"2025-04-01T16:20:15","modified_gmt":"2025-04-01T20:20:15","slug":"des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries","status":"publish","type":"post","link":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/","title":{"rendered":"Des chercheurs d\u00e9veloppent un nouveau moyen d’associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s"},"content":{"rendered":"

A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.<\/p>\n

The team, led by researchers from the University of British Columbia and BC Children\u2019s Hospital Research Institute, is the first in Canada to combine these two techniques to identify and test a drug for a young patient’s tumour in time for their treatment.<\/p>\n

Their success in finding a new drug for the patient, described today in EMBO Molecular Medicine<\/a>, shows how the study of proteins, known as proteomics, can be a valuable complement to the established study of genes (genomics) in real-time cancer therapies.<\/p>\n

The work was a collaborative effort of PROFYLE<\/a> (PRecision Oncology For Young peopLE), a key initiative of the Canadian pediatric cancer network ACCESS (Advancing Childhood Cancer Experience, Science and Survivorship) that brings together more than 30 research and funding organizations and over 100 investigators from across Canada to improve cancer outcomes for children and young adults.<\/p>\n

The study by co-lead authors Dr. Georgina Barnabas, a postdoctoral researcher in Dr. Philipp Lange\u2019s lab, and Tariq Bhat, a PhD student in Dr. James Lim\u2019s lab, focused on an unnamed patient diagnosed with a rare pediatric cancer that resisted conventional treatments.<\/p>\n

Proteomics: A complementary approach to identify treatment<\/h4>\n

While genes carry the instructions to make proteins, proteins themselves are the functional building blocks of our cells. Most drugs work by changing the activity of proteins, so the team wondered if proteomics could uncover hidden weaknesses in tumours that genetic testing alone might miss.<\/p>\n

After standard chemotherapy had failed and the tumour became resistant to a drug selected by genomics, no clear drug candidates emerged from further genetic testing. But instead of stopping there, the team turned to proteomics and discovered that the tumour\u2019s metabolism relied heavily on an enzyme known as SHMT2.<\/p>\n

\u201cWith genomics alone, we couldn\u2019t find a clear treatment option,\u201d said Dr. Lange, who, along with Dr. Lim and clinician Dr. Rebecca Deyell, are senior investigators with the Michael Cuccione Childhood Cancer Research Program<\/a> at BCCHR. \u201cBut by looking at the tumour\u2019s proteins, we found a critical metabolic weakness that we could target with an already approved drug.\u201d<\/p>\n

The researchers\u2019 strategy was to use sertraline, a common antidepressant, to inhibit SHMT2 and cut off the tumour\u2019s access to a key energy source.<\/p>\n

Replicating the tumour on a chicken egg<\/h4>\n

To test their idea, the team used a method that involves growing a small piece of the patient\u2019s tumour on a chicken egg, serving as an avatar host for the tumour. Growing an identical tumour outside the patient gave them a way to test for personalized drug responses in a matter of weeks.<\/p>\n

\u201cThis technique speeds up the process of evaluating a treatment option in a way that simply wouldn\u2019t be possible with traditional methods,\u201d said Dr. Lim. \u201cWe could quickly confirm whether the drug we identified through proteomics could actually work for the patient\u2019s tumour.\u201d<\/p>\n

The chicken egg avatars are part of the BRAvE<\/a> initiative (B<\/strong>etter\u00a0R<\/strong>esponses through\u00a0Av<\/strong>atars and\u00a0E<\/strong>vidence) at BCCHR, which connects clinics with research labs at the hospital.<\/p>\n

The team presented their results to a panel of experts established by PROFYLE, who considered sertraline as the best treatment option for the patient at the time.<\/p>\n

Encouraging results, but more work to be done<\/h4>\n

The results were promising but not a cure. After beginning sertraline treatment, the patient\u2019s tumour growth slowed but did not stop, meaning additional treatment was still needed.<\/p>\n

\u201cWhile there is more work to be done, this study shows that our approach can deliver personalized treatment recommendations fast enough to actually help patients with rare and difficult-to-treat cancers,\u201d said Dr. Lange. \u201cWe now hope to expand this method to other children to identify effective treatments faster across the country.\u201d<\/p>\n

 <\/p>\n

 <\/p>\n

About UBC<\/em><\/strong><\/p>\n

The University of British Columbia is a global centre for research and teaching, consistently ranked among the top public universities in the world. Since 1915, UBC\u2019s entrepreneurial spirit has embraced innovation and challenged the status quo. UBC encourages its students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.<\/em><\/p>\n

About BC Children’s Hospital Research Institute<\/em><\/strong><\/p>\n

BC Children’s Hospital Research Institute conducts discovery, translational and clinical research to benefit the health of children and their families. We are supported by BC Children’s Hospital Foundation; are part of BC Children\u2019s Hospital and the Provincial Health Services Authority; and work in close partnership with the University of British Columbia. For more information, visit <\/em>www.bcchr.ca<\/em><\/a>. <\/em><\/p>\n

About ACCESS<\/em><\/strong><\/p>\n

ACCESS is a pan-Canadian pediatric cancer network advancing childhood cancer experience, science and survivorship. Our network of researchers, healthcare providers, partner organisations, and Persons With Lived Experience believe in equitable access to scientific advances, diagnostic tools, innovative therapies, and supportive care to better health outcomes<\/em> and quality of life for children with cancer and their families. Visit<\/em>\u00a0accessforkidscancer.ca<\/em><\/a>\u00a0for more information. ACCESS is supported by the Canadian Institutes of Health Research (CIHR).<\/em><\/p>\n

Contact:<\/strong>
\nFatyma Khan
\nSenior Advisor, Communications
\n+1 437 999 6370
\nfatyma.khan@sickkids.ca<\/p>\n","protected":false},"excerpt":{"rendered":"

A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins. The team, led by researchers from the University of British Columbia and BC Children\u2019s Hospital Research Institute, is the first in Canada to combine these two techniques… Read more <\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[103],"tags":[],"class_list":["post-3664","post","type-post","status-publish","format-standard","hentry","category-nouvelles"],"acf":[],"yoast_head":"\nDes chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Des chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access\" \/>\n<meta property=\"og:description\" content=\"A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins. The team, led by researchers from the University of British Columbia and BC Children\u2019s Hospital Research Institute, is the first in Canada to combine these two techniques... Read more\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\" \/>\n<meta property=\"og:site_name\" content=\"Access\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-01T20:15:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-01T20:20:15+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-site-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fatyma Khan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@acces_access\" \/>\n<meta name=\"twitter:site\" content=\"@acces_access\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fatyma Khan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\"},\"author\":{\"name\":\"Fatyma Khan\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/24218013c31b0a5c720b1c1c080af386\"},\"headline\":\"Des chercheurs d\u00e9veloppent un nouveau moyen d’associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s\",\"datePublished\":\"2025-04-01T20:15:55+00:00\",\"dateModified\":\"2025-04-01T20:20:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\"},\"wordCount\":894,\"publisher\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#organization\"},\"articleSection\":[\"Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\",\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\",\"name\":\"Des chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access\",\"isPartOf\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#website\"},\"datePublished\":\"2025-04-01T20:15:55+00:00\",\"dateModified\":\"2025-04-01T20:20:15+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des chercheurs d\u00e9veloppent un nouveau moyen d’associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#website\",\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\",\"name\":\"ACCESS\",\"description\":\"Advancing Childhood Cancer Experience, Science & Survivorship\",\"publisher\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/www.accessforkidscancer.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#organization\",\"name\":\"ACCESS\",\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png\",\"contentUrl\":\"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png\",\"width\":696,\"height\":696,\"caption\":\"ACCESS\"},\"image\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/acces_access\",\"https:\/\/www.instagram.com\/access_acces\/\",\"https:\/\/www.linkedin.com\/company\/access-acces\/\",\"https:\/\/www.youtube.com\/channel\/UC0SYgen8vfGlXtikQ8xtQ6A\"]},{\"@type\":\"Person\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/24218013c31b0a5c720b1c1c080af386\",\"name\":\"Fatyma Khan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/79c37f74186f5ee4e2b6cd406ec6d7ec4df6f8e457b4a9f757bed0c35b5ac32a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/79c37f74186f5ee4e2b6cd406ec6d7ec4df6f8e457b4a9f757bed0c35b5ac32a?s=96&d=mm&r=g\",\"caption\":\"Fatyma Khan\"},\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/author\/fatymakhan\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/","og_locale":"fr_FR","og_type":"article","og_title":"Des chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access","og_description":"A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins. The team, led by researchers from the University of British Columbia and BC Children\u2019s Hospital Research Institute, is the first in Canada to combine these two techniques... Read more","og_url":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/","og_site_name":"Access","article_published_time":"2025-04-01T20:15:55+00:00","article_modified_time":"2025-04-01T20:20:15+00:00","og_image":[{"width":1200,"height":675,"url":"http:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-site-image.jpg","type":"image\/jpeg"}],"author":"Fatyma Khan","twitter_card":"summary_large_image","twitter_creator":"@acces_access","twitter_site":"@acces_access","twitter_misc":{"\u00c9crit par":"Fatyma Khan","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#article","isPartOf":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/"},"author":{"name":"Fatyma Khan","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/24218013c31b0a5c720b1c1c080af386"},"headline":"Des chercheurs d\u00e9veloppent un nouveau moyen d’associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s","datePublished":"2025-04-01T20:15:55+00:00","dateModified":"2025-04-01T20:20:15+00:00","mainEntityOfPage":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/"},"wordCount":894,"publisher":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#organization"},"articleSection":["Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/","url":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/","name":"Des chercheurs d\u00e9veloppent un nouveau moyen d'associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s - Access","isPartOf":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#website"},"datePublished":"2025-04-01T20:15:55+00:00","dateModified":"2025-04-01T20:20:15+00:00","breadcrumb":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/des-chercheurs-developpent-un-nouveau-moyen-dassocier-les-jeunes-patients-atteints-de-cancer-aux-medicaments-appropries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.accessforkidscancer.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Des chercheurs d\u00e9veloppent un nouveau moyen d’associer les jeunes patients atteints de cancer aux m\u00e9dicaments appropri\u00e9s"}]},{"@type":"WebSite","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#website","url":"http:\/\/www.accessforkidscancer.ca\/fr\/","name":"ACCESS","description":"Advancing Childhood Cancer Experience, Science & Survivorship","publisher":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.accessforkidscancer.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#organization","name":"ACCESS","url":"http:\/\/www.accessforkidscancer.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png","contentUrl":"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png","width":696,"height":696,"caption":"ACCESS"},"image":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/acces_access","https:\/\/www.instagram.com\/access_acces\/","https:\/\/www.linkedin.com\/company\/access-acces\/","https:\/\/www.youtube.com\/channel\/UC0SYgen8vfGlXtikQ8xtQ6A"]},{"@type":"Person","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/24218013c31b0a5c720b1c1c080af386","name":"Fatyma Khan","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/79c37f74186f5ee4e2b6cd406ec6d7ec4df6f8e457b4a9f757bed0c35b5ac32a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/79c37f74186f5ee4e2b6cd406ec6d7ec4df6f8e457b4a9f757bed0c35b5ac32a?s=96&d=mm&r=g","caption":"Fatyma Khan"},"url":"http:\/\/www.accessforkidscancer.ca\/fr\/author\/fatymakhan\/"}]}},"_links":{"self":[{"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/posts\/3664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/comments?post=3664"}],"version-history":[{"count":0,"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/posts\/3664\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=3664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/categories?post=3664"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/tags?post=3664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}